1 |
Erridge SC, Thomson CS, Davidson J, "Scottish Cancer Trials Lung Group and The Scottish Cancer Therapy Network. Factors influencing the use of thoracic radiotherapy in lung cancer an analysis of the 1995 Scottish lung cancer audit", Clin Oncol (R Coll Radiol), 14, 219-227, 2002.
DOI
ScienceOn
|
2 |
Firat S, Byhardt RW, Gore E, "The effects of comorbidity and age on RTOG study enrollment in Stage III non-small cell lung cancer patients who are eligible for RTOG studies", Int J Radiat Oncol Biol Phys, 78, 1394-1399, 2010.
DOI
ScienceOn
|
3 |
"Annual report of cancer statistics in Korea in 2012", Ministry of Health and Welfare. Korea Central Cancer Registry, National Cancer Center, 2012.
|
4 |
Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, "Lung cancer In AJCC Cancer Staging Manual. 7th edition", Edited by American Joint Committee on Cancer (AJCC). New York: Springer-Verlag, 299-323, 2010.
|
5 |
Solda F, Lodge M, Ashley S, "Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; Systematic review and comparison with a surgical cohort", Radiotherapy and Oncology, 109:1-7, 2013.
DOI
ScienceOn
|
6 |
Langendijk JA, ten Velde GPM, Aaronson NK, "Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective study", Int J Radiat OncolBiol Phys, 47, 149-155, 2000.
DOI
ScienceOn
|
7 |
Von Dincklage JJ, Ball D, Silvestri GA, "A review of clinical practice guidelines for lung cancer", J Thorac Disease,(suppl 5), 5, S607-S622, 2013.
|
8 |
Tyldesley S, Boyd C, Schulze K, "Estimating the need for radiotherapy for lung cancer: an evidence-based epidemiologic approach", Int J Radiat Oncol Biol Phys, 49, 973-985, 2001.
DOI
ScienceOn
|
9 |
The Cancer Council Australia, "Clinical Practice Guidelines for the Prevention, Diagnosis and Management of Lung Cancer. Canberra, New South Wales", Australia: National Health and Medical Research Council, 2004.
|
10 |
Ontario Cancer Treatment and Research Foundation, "A plan for radiation treatment, province of Ontario", 1995-2000.
|
11 |
Koning CC, Aarts MJ, Struikmans H, "Mapping use of radiotherapy for patients with non-small cell lung cancer in the Netherlands between 1997 and 2008", Clin Oncol (R Coll Radiol), 24, e46-e53, 2012.
DOI
ScienceOn
|
12 |
Delaney G, Barton M, Jacob S, "A model for decision making for the use of radio- therapy in lung cancer", Lancet Oncol, 4, 120-128, 2003
DOI
ScienceOn
|
13 |
Barbera L, Zhang-Salomons J, Huang J, Tyldesley S, Mackillop W, "Defining the need for radiotherapy for lung cancer in the general population: a criterion-based,benchmarking approach", Med Care, 41:1074-1085, 2003.
DOI
ScienceOn
|
14 |
Oken MM, Creech RH, Tormey DC, et al, "Toxicity and response criteria of the Eastern Cooperative Oncology Group", Am J Clin Oncol 5, 649-655, 1982
DOI
|
15 |
Shalini K. Vinod, MBBS, MD, FRANZCR, "Underutilization of Radiotherapy for Lung Cancer in New South Wales", Australia. Cancer, pp. 686-694. 2010.
|
16 |
london cancer alliance, "LCA Lung Cancer Clinical Guidelines December",[.nhs.uk], 2013
|
17 |
Clinical Guide line of the lung cancer,"Korean Association for the Study of Lung Cancer(2nd ed)", 2011.
|
18 |
Goffin J Lacchetti C, Ellis PM, Ung YC, "Evans WK: Fist-line chemotherapy in the treatment of advanced non-small cell lung cancer. A systematic review", J ThoracOncol, 5, 260-274, 2010.
|
19 |
Laroche C, Wells F, Coulden R. Improving surgical resection rate in lung cancer. Thorax, 53, 445-449, 1998.
DOI
|
20 |
Ball DL, Fisher R, Burmeister B, "Stage is not a reliable indicator of tumor volume in non-small cell lung cancer: a preliminary analysis of the Trans-Tasman Radiation Oncology Group 99-05 database", J Thorac Oncol1, 667-672, 2006.
|
21 |
Hayman JA, Abrahamse PH, Lakhani I, "Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancer", Int J Radiat Oncol Biol Phys, 69, 1001-1007, 2007.
DOI
ScienceOn
|
22 |
Erridge SC, Thomson CS, Davidson J, "Scottish Cancer Trials Lung Group and The Scottish Cancer Therapy Network. Factors influencing the use of thoracic radiotherapy in lung cancer--an analysis of the 1995 Scottish lung cancer audit", Clin Oncol (R Coll Radiol), 14, 219-227, 2002.
DOI
ScienceOn
|
23 |
Stevens G, Stevens W, Purchuri S, "Radiotherapy utilization in lung cancer in New Zealand: disparities with optimal rates explained", NZ Med J, 122, 43-54, 2009.
|
24 |
Vinod SK, Barton MB, "Actual versus optimal utilization of radiotherapy in lung cancer: Where is the shortfall?", Asia-Pacific J Clin Oncol, 3, 1-7, 2007.
DOI
ScienceOn
|
25 |
Tyldesley S, Zhang-Salomons J, Groome PA, "Association between age and the utilization of radiotherapy in Ontario", Int J Radiat Oncol Biol Phys, 47, 469-480, 2000.
DOI
ScienceOn
|
26 |
Erridge SC, Murray B, Price A, "Improved treatment and survival for lung cancer patients in South-East Scotland", J Thorac Oncol, 3, 491-498, 2008.
DOI
ScienceOn
|
27 |
Laroche C, Wells F, Coulden R, "Improving surgical resection rate in lung cancer", Thorax, 53, 445-449, 1998.
DOI
|
28 |
Wassenaar TR, Eick hoff JC, Jarzemsky D, "Differences inprimary care clinicians' approach to non-small cell lung cancer patients compared with breast cancer", J Thorac Oncol, 2, 722-728, 2007.
DOI
|